The University of British Columbia (UBC) Okanagan campus is a research hub located in the middle of British Columbia’s beautiful Okanagan Valley, and ranked among the world’s top 20 public universities. We’ve seen plenty of innovative 3D printing research coming out of UBC Okanagan, and a lot of the work has centered around the biomedical field.
Currently, researchers from the university’s School of Engineering and Department of Chemistry are working on a new 3D printing method for producing living bio-tissues, which could one day be a valuable tool for advancing cancer research and tissue replacement.
Assistant engineering professor Keekyoung Kim explained, “One of the ultimate goals in biomedical engineering is to recreate viable, healthy and living tissues. The applications are staggering and could range from helping people suffering from ailments such as severe burns or organ failure to creating artificial tissues for research into diseases like cancer.”
Kim’s team developed a new method, called direct laser bioprinting (DLBP), which solidifies a hydrogel into a complex cross-linked platform with the help of an inexpensive laser diode.
The system has successfully 3D printed artificial tissue at a resolution much finer than currently possible with other methods, and is able to support live, healthy cells with 95% effectiveness. These engineered tissues are strong enough to provide a structure for the living cells to live, and even thrive.
The researchers published a paper on their work, titled “A Novel, Well-Resolved Direct Laser Bioprinting System for Rapid Cell Encapsulation and Microwell Fabrication,” in the Advanced Healthcare Materials journal; co-authors include UBC Okanagan graduate students Zongje Wang and Xian Jin, Zhenlin Tian, chemistry professor Frederic Menard, engineering professor Jonathan Holzman, and Kim.
The abstract reads, “A direct laser bioprinting (DLBP) system is introduced in this work. The DLBP system applies visible-laser-induced photo-crosslinking at a wavelength of 405 nm using the photoinitiator VA-086. It is shown that such a system can fabricate vertical structures with fine features (less than 50 µm) and high cell viability (greater than 95%). Experimental characterizations and theoretical simulations are presented, and good agreement is seen between the experiments and theory. The DLBP system is applied to the fabrication of (1) cell-laden hydrogel microgrids, (2) hydrogel microwells, as well as a test of (3) cell encapsulation, and (4) cell seeding. The DLBP system is found to be a promising tool for bioprinting.”
Copious amounts of research have been done regarding 3D printing tissue, and Kim says that this kind of work is important because the demand for biological models that researchers can grow cancer cells on in three dimensions is so high. He also stated that living cells, like the kind in his team’s work, are very sensitive to biological, chemical, and mechanical conditions that you’ll only see in a 3D environment.
“These findings show a promising future for tissue engineering and medical research. We’re already looking at applying the technology to cancer research,” Kim said.
The research was part of an interdisciplinary project from UBC Okanagan’s School of Engineering and Department of Chemistry, and supported by Discovery Grants from both the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Foundation for Innovation John R. Evans Leaders Opportunity Fund. Holzman says that this type of research is “perfectly suited to interdisciplinary research.”
Holzman said, “Bio-tissue printing applies knowledge in biology, chemistry, and microfabrication toward the health sciences. I think our recent success in bio-tissue printing came about from the multidisciplinary nature of our team.”
The UBC Okanagan team tested if their 3D printed artificial tissue would be able to provide proper support for healthy, living cells by building a pattern which, as the university put it, “encapsulated a commonly used line of breast cancer cells.”
Kim explained, “The tissue pattern, which has extremely fine features and high cell viability, firmly demonstrates that our system has real potential to create functional, engineered tissue. I’m excited by what this could bring to biomedical research.”
Discuss this research, and other 3D printing topics, at 3DPrintBoard.com or share your thoughts in the Facebook comments below.[Images: UBC Okanagan]
You May Also Like
3D Printing News Briefs, September 12, 2020: DSM, MakerOS, Evolve Additive Solutions, & Print Parts Inc.
3D Printing News Briefs runs the gamut today from materials and software to business. First, DSM is announcing a new food-safe 3D printing material, and MakerOS has a new software...
Thanks to New Round, Xometry Raised $193M Total in Funding Since 2013
Maryland-based Xometry, a custom on-demand manufacturing marketplace which recently launched a video interview series and announced a partnership with ExOne to offer metal binder jetting services, has more exciting news to...
3D Printing News Briefs, September 5, 2020
In today’s 3D Printing News Briefs, the former CEO of Carbon has joined the faculty of a prestigious university. Moving on, a 3D printing whiz and Tel Aviv professor has...
3D Printing News Briefs, August 30, 2020: Roboze, BCN3D & CREA3D, 3D Systems, ASTM International
We’re covering 3D printing business stories in today’s 3D Printing News Briefs, including investments, partnerships, industry executives, and annual reports. Federico Faggin, who invented the microprocessor, is investing in Roboze,...
View our broad assortment of in house and third party products.